Immunohistochemistry (IHC) Market Research Reveals Strong 10.1% CAGR Outlook Through 2030

The Business Research Company’s Immunohistochemistry (IHC) Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ — “The immunohistochemistry (IHC) market has been expanding rapidly in recent years, driven by advancements in cancer diagnostics and clinical research. This market shows strong promise for continued growth as new technologies and applications emerge. Let’s explore the current market size, key growth factors, regional outlook, and the trends shaping the future of the IHC landscape.

Immunohistochemistry Market Size and Expected Growth by 2026
The IHC market has witnessed significant expansion, valued at $2.76 billion in 2025. It is projected to increase to $3.05 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. This past growth has largely been fueled by the rising use of IHC techniques in cancer diagnostics, the establishment of more hospital pathology labs, greater accessibility to monoclonal antibodies, wider acceptance of tissue-based diagnostic methods, and a surge in clinical research activities.

Download a free sample of the immunohistochemistry (ihc) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Forecast for the Immunohistochemistry Market Through 2030
Looking ahead, the immunohistochemistry market is expected to continue its strong upward trajectory, reaching $4.47 billion by 2030 with a CAGR of 10.1%. Key factors driving this growth include the increasing demand for precision oncology diagnostics, the integration of AI-powered pathology analysis, the expansion of biomarker-driven drug discovery, wider use of multiplex tissue profiling, and greater investment in advanced pathology infrastructure. Among the notable trends are the growing implementation of automated IHC staining systems, adoption of multiplex IHC methods, enhanced incorporation of digital pathology platforms, growth in companion diagnostic applications, and a heightened focus on high-specificity antibodies.

Understanding Immunohistochemistry and Its Diagnostic Role
Immunohistochemistry is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This process is visualized through either chromogenic detection, involving enzyme-substrate reactions, or fluorescent detection using fluorescent dyes, enabling precise localization of target molecules.

View the full immunohistochemistry (ihc) market report:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Personalized Medicine as a Key Driver of IHC Market Expansion
The rising demand for personalized medicine is a crucial factor propelling the immunohistochemistry market. Personalized medicine tailors medical treatments and decisions to individual patients based on their unique genetic and environmental profiles. IHC plays an essential role in this approach by detecting specific protein markers, which helps in accurately classifying tumors and diagnosing diseases. For instance, in February 2024, the Personalized Medicine Coalition reported that more than one-third of new drug approvals by the US Food and Drug Administration (FDA) in 2023 were personalized medicines. That year alone, the FDA approved 16 new personalized therapies for rare disease patients, compared to just 6 in 2022, underscoring the growing influence of personalized care on the IHC market.

Regional Outlook of the Immunohistochemistry Market
In 2025, North America held the largest share of the global immunohistochemistry market. Meanwhile, the Asia-Pacific region is expected to show the fastest growth in the coming years. The market report covers key geographic areas including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive perspective on regional developments and opportunities.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company – www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Media gallery

About The Author

Written By: EIN Presswire